A study of 136 patients with advanced cancers performed by UCSD oncologist and CureMatch co-founder Dr. Razelle Kurzrock and colleagues suggested that combination therapy may be more efficacious than single-drug therapy.
This webpage is strictly reserved for healthcare professionals. Please confirm that you are a healthcare professional.
Otherwise, you will be redirected to the institutional part of this website.
Thank you for your understanding.